|
|
Line 178: |
Line 178: |
| |} | | |} |
|
| |
|
| | |
| | |
| | <br><br><br><br> |
| | <br><br><br><br> |
| | <br><br><br><br> |
|
| |
|
|
| |
|
Revision as of 16:12, 20 May 2014
Hematogenous Osteomyelitis
Empiric Therapy
▸ Click on the following categories to expand treatment regimens.
▸ Children (>4 months) - Adults
|
Staph aureus (most common)
|
Preferred Regimen
|
▸ Vancomycin 1 gm IV q12h, if over 100 kg, 1.5 gm IV q12h
|
Alternative Regimen
|
▸ Nafcillin 2 gm IV q4h OR ▸ Oxacillin 2 gm IV q4h
|
|
Specific Therapy
▸ Click on the following categories to expand treatment regimens.
▸ Methicillin-sensitive S.aureus
▸ Methicillin-resistant S.aureus
|
MRSA
|
Preferred Regimen
|
▸ Vancomycin 1 gm q12h IV
|
Alternative Regimen
|
▸ Linezolid 600 mg q12h IV/po ± ▸ Rifampin 300 mg po/IV bid
|
|
Salmonella (Gram-negative bacilli)
|
Preferred Regimen
|
▸ Ciprofloxacin 400 mg IV q12h
|
Alternative Regimen
|
▸ Levofloxacin 750 mg IV q24h
|
|
Contiguous Osteomyelitis Without Vascular Insufficiency
Empiric Therapy
▸ Click on the following categories to expand treatment regimens.
▸ Methicillin-sensitive S.aureus
▸ Methicillin-resistant S.aureus
|
MRSA
|
Preferred Regimen
|
▸ Vancomycin 1 gm q12h IV
|
Alternative Regimen
|
▸ Linezolid 600 mg q12h IV/po ± ▸ Rifampin 300 mg po/IV bid
|
|
Salmonella (Gram-negative bacilli)
|
Preferred Regimen
|
▸ Ciprofloxacin 400 mg IV q12h
|
Alternative Regimen
|
▸ Levofloxacin 750 mg IV q24h
|
|
|
|
|